| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Research Officer | Senior Vice President, R&D | Senior Vice President, R&D
1 company
Rote William E. serves as a Chief Research Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 59 sells. Those positions are worth an estimated $6.2M at current prices.
Historically, Rote William E.'s trades have earned a middling insider score of 58/100 across 20 rated trades. Over a 12-month horizon, 44.4% of those trades were profitable, with an average 12-month return of -15.7%.
The biggest single holding is TVTX (~$6.2M) as Chief Research Officer. The recent filings there lean toward selling, a net 385,539 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 4,764 | $8.71 | $41,495.10 | -5.6% | -30.2% | +137.9% | |
| Jan 23, 2024 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,062 | $8.96 | $18,475.52 | -3.3% | -37.0% | +109.5% | |
| Sep 5, 2023 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,815 | $14.71 | $26,698.65 | -2.9% | -55.7% | -29.2% | |
| May 10, 2023 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell10b5-1 | 825 | $16.59 | $13,686.75 | -1.4% | -4.8% | -59.5% | |
| Feb 1, 2023 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,590 | $22.25 | $57,627.50 | -4.1% | -29.2% | -61.1% | |
| Jan 24, 2023 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,062 | $21.50 | $44,333.00 | -4.6% | -2.9% | -58.3% | |
| May 11, 2022 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,563 | $21.71 | $33,940.25 | -3.5% | +30.5% | -24.4% | |
| Jan 31, 2022 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,125 | $27.40 | $30,825.00 | -2.4% | -6.4% | -18.5% | |
| Jan 24, 2022 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,875 | $24.98 | $46,837.50 | -4.9% | +9.9% | -16.2% | |
| Jan 11, 2022 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,500 | $27.40 | $68,500.00 | -6.1% | +3.2% | -25.6% |